 The genomic promise of cancer as “not-yet-treatable” and the moral burden of “trying”Isabel Briz Hernández Social Science & Medicine, 2025, vol. 366, issue C Abstract: Based on fieldwork conducted in China from November 2018 to January 2020 on biomedical innovation with advanced therapies open to foreigners, in this paper I address the question of why parents of children with incurable cancer decide to access experimental treatment on the other side of the world. While work on the “political economy of hope” has already extensively researched the relation between biomedical technology and hope, I delve into other terrains. In this paper, I will discuss the role of “ontological hope” in the moral project of caring for a child with cancer. Drawing on the Anthropology of Ethics, I conclude that in the postgenomic era, when incurable cancers are recategorize as not-yet-treatable, parents’ efforts to access experimental treatment highlight the complex moral work that parents must undergo to imagine a future good life despite their irreparable loss. Keywords: Genomic medicine; Advanced therapies; China; Ethics; Hope; Cancer; Agent-regret (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:eee:socmed:v:366:y:2025:i:c:s0277953625000097 Ordering information: This journal article can be ordered from DOI: 10.1016/j.socscimed.2025.117680 Access Statistics for this article Social Science & Medicine is currently edited by Ichiro (I.) Kawachi and S.V. (S.V.) Subramanian More articles in Social Science & Medicine from Elsevier |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.